Type 1 interferon supports B cell responses to polysaccharide antigens but is not required for MPL/TDCM adjuvant effects on innate B cells is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2021). On theSindex it has a DataRank of 0.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 5T32AI007401-17
Training Program in Immunology and Pathogenesis
National Institutes of Health
Grant: 5R21AI144758-02
Developing effective adjuvants for native polysaccharide antigen-based vaccines
National Institutes of Health
Grant: 1UL1TR001420-01
Wake forest Clinical and Translational Science Award
Fields of Study
Sustainable Development Goals